Supplements and Featured Publications
Oncology-Centric Biosimilar Implementation at M Health Fairview: A Review of Process and Perspective
Assessing the Impact of Immunotherapy on Quality of Life and Patient Outcomes in the Frontline Management of Advanced Non−Small Cell Lung Cancer
Examining Unmet Needs in the Management of Eosinophilic Esophagitis
Population Health Implications of Cardiorenal Metabolic Syndrome
Exclusive Coverage of the European Society for Medical Oncology 2021 Congress
Highlights from the European Society of Medical Oncology 2021 Congress, which took place September 16-21, 2021, in a virtual format.
Strategies for Effective Cardiovascular Risk Management Through Lipid Management: A Transitional Approach From Hospital to Home
Innovative Enhanced Medication Therapy Management Model: MedWise Risk Score, Medication Safety Review, and Health Care Outcomes
Volume: 27
Issue: 16
Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis: Pathophysiology, Diagnosis, and the Evolving Treatment Landscape
Volume: 27
Issue: 15
Profiles in Care: Importance of a Coordinated Health Care Plan in Plaque Psoriasis and Psoriatic Arthritis Management
MS Stakeholder Summit: New Treatment Landscape in Multiple Sclerosis (MS)—Preventing Long-Term Disability Through High-Efficacy Treatments in Early MS
AJMC® Roundtable: Defining Value for the Treatment of Brain Metastases in HER2+ Metastatic Breast Cancer
Utilizing Oncology Biosimilars to Minimize the Economic Burden Associated With Cancer Treatment: Managed Care Considerations
Volume: 26
Issue: 14
Optimizing the Value of CAR T-Cell Therapy: Managed Care Considerations From Recent Clinical Findings
Volume: 27
Issue: 13
Addressing the Role of Edaravone in the Management of Amyotrophic Lateral Sclerosis and Gaps in Care and Access: Expert Panel Recommendations
Volume: 27
Issue: 12
The Effect of Antibiotic Resistance on the Management of Helicobacter pylori Infection
Outcomes-Based Agreements Give New Insight for Treatment of Diabetes and Cardiovascular Disease
New Horizons in the Treatment of Basal Cell Carcinoma
The Role of Real-world Evidence in the Evolving Treatment Landscape of Multiple Myeloma
Evolving Evidence-Based Treatment Guidelines for Iron Deficiency Anemia in Inflammatory Bowel Disease: Considerations in Managed Care
Volume: 27
Issue: 11
Long-Term Safety and Efficacy of Subcutaneous Immunoglobulin IgPro20 in Chronic Inflammatory Demyelinating Polyneuropathy
Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities
Discerning Heart Failure: New Treatment Approaches for Preserved or Reduced Ejection Fraction Subtypes
Volume: 27
Issue: 9
Moderate to Severe Psoriasis: Considerations for Patient Management Amid a Changing Treatment Spectrum
Volume: 27
Issue: 10
Considerations for Future Management of Autoimmune Therapies
Addressing Primary and Secondary Prevention of Osteoporosis-Related Fractures
Burden of Illness of Chronic Kidney Disease in Patients With Type 2 Diabetes
Volume: 27
Issue: 8
New Directions in the Management of Interstitial Lung Disease
Volume: 27
Issue: 7
Advancements in Treatment for Hypertrophic Cardiomyopathy: Key Considerations for Managed Care Professionals
Volume: 27
Issue: 6
Combining Immune Checkpoint Inhibitors With Chemotherapy for the Treatment of Metastatic Triple-Negative Breast Cancer: An Overview for Managed Care Professionals
Volume: 27
Issue: 5
Hyperlipidemia: Effective Disease Management to Decrease Economic and Quality of Life Burden
Volume: 27
Issue: 4
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
Making the Genetic Models Match the Ancestry of Patient Populations
3
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
4
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
5
